177
Participants
Start Date
March 3, 2022
Primary Completion Date
August 19, 2024
Study Completion Date
January 30, 2026
Belantamab mafodotin
Belantamab mafodotin will be administered.
GSK Investigational Site, Dublin
GSK Investigational Site, Taipei
GSK Investigational Site, Taipei
GSK Investigational Site, Taichung
GSK Investigational Site, Tainan City
GSK Investigational Site, Ciudad Autonoma de Buenos Aire
GSK Investigational Site, Liverpool
GSK Investigational Site, Newcastle
GSK Investigational Site, East Melbourne
GSK Investigational Site, Bern
GSK Investigational Site, Woodville
GSK Investigational Site, New York
GSK Investigational Site, Bangkok
GSK Investigational Site, Bangkok
GSK Investigational Site, Athens
GSK Investigational Site, Athens
GSK Investigational Site, Alessandria
GSK Investigational Site, Genova
GSK Investigational Site, Girona
GSK Investigational Site, Greifswald
GSK Investigational Site, Hamburg
GSK Investigational Site, Rio Patras
GSK Investigational Site, Oviedo
GSK Investigational Site, West Palm Beach
GSK Investigational Site, Nashville
GSK Investigational Site, Chattanooga
GSK Investigational Site, Khon Kaen
GSK Investigational Site, Taichung
GSK Investigational Site, Reggio Emilia
GSK Investigational Site, Ferrara
GSK Investigational Site, Orléans
GSK Investigational Site, Valencia
GSK Investigational Site, Meldola FC
GSK Investigational Site, Rimini
GSK Investigational Site, Pusan
GSK Investigational Site, Chiang Mai
GSK Investigational Site, Hwasun
GSK Investigational Site, Ascoli Piceno
GSK Investigational Site, Kansas City
GSK Investigational Site, Houston
GSK Investigational Site, Avignon
GSK Investigational Site, Córdoba
GSK Investigational Site, Ahmedabad
GSK Investigational Site, Sushrut Hospital and Research
GSK Investigational Site, Pune
GSK Investigational Site, Apex Wellness Hospital
GSK Investigational Site, Hyderabad
GSK Investigational Site, M S R Nagar Msrit Post
GSK Investigational Site, Kolkata
GSK Investigational Site, Kolkata
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Capital Federal
GSK Investigational Site, Pilar
GSK Investigational Site, Rosario
GSK Investigational Site, Joinville
GSK Investigational Site, Porto Alegre
GSK Investigational Site, Rio de Janeiro
GSK Investigational Site, Salvador
GSK Investigational Site, São Paulo
GSK Investigational Site, São Paulo
GSK Investigational Site, Oshawa
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Nice
GSK Investigational Site, Cottbus
GSK Investigational Site, Dresden
GSK Investigational Site, Athens
GSK Investigational Site, Dublin
GSK Investigational Site, Cagliari
GSK Investigational Site, Mexico City
GSK Investigational Site, Mexico City
GSK Investigational Site, Bydgoszcz
GSK Investigational Site, Gdansk
GSK Investigational Site, Katowice
GSK Investigational Site, Lublin
GSK Investigational Site, Poznan
GSK Investigational Site, Torun
GSK Investigational Site, Warsaw
GSK Investigational Site, Wałbrzych
GSK Investigational Site, Wroclaw
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Albacete
GSK Investigational Site, Barcelona
GSK Investigational Site, Terrassa - Barcelona
GSK Investigational Site, Leicester
GSK Investigational Site, London
GSK Investigational Site, Stoke-on-Trent
Lead Sponsor
GlaxoSmithKline
INDUSTRY